P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,670.05
12.15 (0.21%)
BSENSE

Sep 07, 03:14 PM

BSE+NSE Vol: 3.53 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.11%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 56.11%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.77%

stock-summary

Interest

Growth in half year ended Sep 2025 is -31.43%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
663.66
464.90
198.76
42.75%
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
464.90
198.76
42.75%
Raw Material Cost
137.67
87.70
49.97
56.98%
Purchase of Finished goods
34.95
34.10
0.85
2.49%
(Increase) / Decrease In Stocks
-10.23
-9.30
-0.93
-10.00%
Employee Cost
109.89
64.40
45.49
70.64%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
180.77
109.90
70.87
64.49%
Total Expenditure (Excl Depreciation)
453.05
286.80
166.25
57.97%
Operating Profit (PBDIT) excl Other Income
210.61
178.10
32.51
18.25%
Other Income
8.98
11.90
-2.92
-24.54%
Operating Profit (PBDIT)
219.59
190.00
29.59
15.57%
Interest
0.24
0.90
-0.66
-73.33%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
219.35
189.10
30.25
16.00%
Depreciation
11.52
6.50
5.02
77.23%
Profit Before Tax
207.83
182.60
25.23
13.82%
Tax
53.11
46.00
7.11
15.46%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
154.72
136.60
18.12
13.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
154.72
136.60
18.12
13.27%
Equity Capital
16.60
23.00
-6.40
-27.83%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
93.20
59.39
33.81
56.93%
Diluted Earnings per share
93.21
59.31
33.90
57.16%
Operating Profit Margin (Excl OI)
31.73%
38.31%
0.00
-6.58%
Gross Profit Margin
33.05%
40.68%
0.00
-7.63%
PAT Margin
23.31%
29.38%
0.00
-6.07%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.11%

Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 56.11%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.77%

Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -31.43%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024